A method for preparing tiamulin fumarate

By controlling the reaction conditions and crystallization method in a continuous flow microchannel reactor, the problems of high impurities and low yield in the synthesis of tiamulin fumarate have been solved, achieving high-yield and high-purity tiamulin production, which is suitable for the veterinary drug industry.

CN117964528BActive Publication Date: 2026-11-10HEBEI MEIHE PHARM CO LTD
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
CN202311853506.2
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2023-12-29
Publication Date
2026-11-10
Estimated Expiration
2043-12-29

AI Technical Summary

Technical Problem

Existing methods for synthesizing tiamulin fumarate suffer from problems such as numerous reaction impurities, low yield, and high cost. In particular, the use of 2-diethylaminoethylthiol introduces toxicity and makes monitoring difficult, thus impacting market size.

Method used

A continuous flow microchannel reactor was used to control the reaction conditions. Tiamulin base was generated by reacting p-toluenesulfonic acid truncated pleurotin ester with cyclothioethane and diethylamine. The base then crystallized in a mixed solution of anhydrous ethanol and n-hexane, reducing side reactions and improving yield and purity.

Benefits of technology

The synthesis of tiamulin with high yield and high purity was achieved, which complies with the regulations of the Veterinary Pharmacopoeia, reduces production costs and purification difficulty, and simplifies the recrystallization process.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure SMS_1
    Figure SMS_1
  • Figure SMS_2
    Figure SMS_2
  • Figure SMS_3
    Figure SMS_3
Patent Text Reader

Abstract

This invention relates to a method for preparing tiamulin fumarate, comprising the following steps: First, truncated pleurotin is used as a raw material and reacted with 4-toluenesulfonyl chloride to generate truncated pleurotin p-toluenesulfonic acid ester. Then, the truncated pleurotin p-toluenesulfonic acid ester reacts with cyclothioethane and diethylamine in a continuous flow microchannel reactor to generate tiamulin base; subsequently, it reacts with fumaric acid to form a salt, generating tiamulin fumarate. The continuous flow microchannel reactor includes a mixing module A, a reaction module B, a mixing module C, a reaction module D, a reaction module E, and a reaction module F connected in series. Cyclothioethane and diethylamine are pumped into mixing module A, and the truncated pleurotin p-toluenesulfonic acid ester solution is pumped into mixing module B. This invention is simple to operate, has mild reaction conditions, high yield, good product purity, and eliminates the need to purchase the raw material 2-diethylaminoethyl mercaptan.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention relates to the field of fumarate tiamulin preparation technology, specifically to a method for preparing fumarate tiamulin. Background Technology

[0002] Tiamulin fumarate is a pluromulin antibiotic prepared by semi-synthesis and salt formation from truncated pleuromedullary material produced by fermentation. It is the first truncated pleuromedullary antibiotic specifically for animals and has a very broad application prospect in the veterinary drug industry and in the prevention and treatment of livestock and poultry diseases.

[0003] Currently, most methods for synthesizing tiamulin fumarate use 2-diethylaminoethylthiol as the main reactant. The problem is that this compound has high toxicity and is also a major raw material for the synthesis of nitrogen mustard. Its use and procurement are subject to strict monitoring by many departments, which not only increases the additional control costs of tiamulin fumarate but also makes it more difficult to purchase, thus restricting the market size of tiamulin fumarate.

[0004] To address the aforementioned issues, Chinese invention patent application number 201410842597.4 discloses a one-pot synthesis method for tiamulin. This method involves reacting p-toluenesulfonic acid truncated pleurotin ester with cyclothioethane and diethylamine in an organic solvent at 50°C for 2-24 hours to synthesize tiamulin base in one pot. However, the coexistence of these three substances leads to numerous side reactions: polymerization of cyclothioethane itself, side reactions between the 14-position toluenesulfonic acid group and cyclothioethane, and side reactions between the 11-position hydroxyl group and cyclothioethane. This results in excessive impurities in the reaction. Even with the reaction temperature controlled at only 50°C, the maximum yield is only 55%, significantly increasing both raw material costs and product purification costs. Summary of the Invention

[0005] The purpose of this invention is to overcome the shortcomings of the prior art and provide a method for preparing tiamulin fumarate, which is simple to operate, has mild reaction conditions, high yield, good product purity, and does not require the purchase of raw material 2-diethylaminoethylthiol.

[0006] To achieve the above objectives, the technical solution adopted by the present invention is as follows:

[0007] A method for preparing tiamulin fumarate includes the following steps:

[0008] First, pylori is used as a raw material and reacted with 4-toluenesulfonyl chloride to generate pylori ester of p-toluenesulfonic acid. Then, pylori ester of p-toluenesulfonic acid reacts with cyclothioethane and diethylamine in a continuous flow microchannel reactor to generate tiamulin base. Then, it reacts with fumaric acid to form a salt to generate tiamulin fumarate.

[0009] The continuous flow microchannel reactor comprises a mixing module A, a reaction module B, a mixing module C, a reaction module D, a reaction module E, and a reaction module F connected in series. The specific steps for the reaction of truncated pleurotin methylbenzenesulfonate with cyclothioethane and diethylamine in the continuous flow microchannel reactor to generate tiamulin alkaloid include:

[0010] First, cyclothioethane and diethylamine are pumped into mixing module A. After being mixed evenly in mixing module A, they enter reaction module B, where an addition reaction occurs to generate part of 2-diethylaminoethanethiol. This then flows into mixing module B and mixes with the p-toluenesulfonic acid truncated pleurotin ester solution. The mixture then flows sequentially through reaction modules D, E, and F. In reaction modules D, E, and F, the remaining cyclothioethane and diethylamine react to generate 2-diethylaminoethanethiol. Simultaneously, 2-diethylaminoethanethiol undergoes a alkylation reaction with p-toluenesulfonic acid truncated pleurotin ester to generate tiamulin base. The reaction solution containing tiamulin base is then discharged.

[0011] As a further technical solution, the molar ratio of truncated pleurotin methylbenzenesulfonic acid ester, cyclothioethane and diethylamine pumped in per unit time is 1:1.02-1.10:2.0-2.5.

[0012] As a further technical solution, the temperature of reaction module B is 60-65℃, the reaction temperature of reaction module D is 40-55℃, and the temperature decreases by 4-6℃ from reaction module D to reaction module F.

[0013] As a further technical solution, the pressure of the microchannel reaction device is controlled at 2-3 MPa (test pressure of the pressure gauge).

[0014] As a further technical solution, blue light is turned on in reaction modules B, D, E, and F.

[0015] As a further technical solution, the wavelength of the blue light is 460-480nm.

[0016] As a further technical solution, the residence time of the material in mixing module A is 45-75 seconds.

[0017] As a further technical solution, the residence time of the material in the mixing module C is 15-25 seconds;

[0018] As a further technical solution, the reaction residence time of the material in reaction module B is 8-12 seconds;

[0019] The total reaction residence time in reaction modules D to F is 24-36 s.

[0020] As a further technical solution, the diameters of reaction modules B, D, E, and F are 150-250 micrometers.

[0021] As a further technical solution, the liquid holding capacity of reaction module B, reaction module D, reaction module E and reaction module F are all 3-5 mL.

[0022] As a further technical solution, the truncated pleurotin ester solution of toluenesulfonic acid is a reaction solution containing truncated pleurotin ester of toluenesulfonic acid obtained by sulfonation reaction.

[0023] As a further technical solution, using truncated pleurotin as a raw material, a sulfonation reaction is carried out with 4-toluenesulfonyl chloride to generate truncated pleurotin p-toluenesulfonic acid ester, specifically including the following steps:

[0024] Add methyl isobutyl ketone solvent to truncated pleurotin, heat to 60°C, stir to dissolve, add alkaline water (sodium hydroxide solution) dropwise, then add 4-toluenesulfonyl chloride, and carry out sulfonation reaction at 45-55°C to generate truncated pleurotin ester of methylbenzenesulfonate. After reacting for 10-20 minutes, stop the reaction to obtain a reaction solution containing truncated pleurotin ester of p-methylbenzenesulfonate.

[0025] As a further technical solution, the discharged reaction solution containing tiamulin alkaloids is separated into layers under vacuum conditions, the water layer is removed, and the organic layer of tiamulin alkaloids is collected and reacted with fumaric acid to form a salt.

[0026] As a further technical solution, the reaction with fumaric acid to form a salt specifically includes: washing the organic layer of tiamulin base with water, then vacuum distilling it at 70-80℃ until no bubbles are generated, cooling it to room temperature, adding a mixed solution of anhydrous ethanol and n-hexane with a volume ratio of 2:1, heating it to 50-60℃, stirring to dissolve it, adding fumaric acid, keeping it at 52-58℃ for 1.5 hours, cooling it to 10℃, cooling to crystallize, filtering it, and washing the crystals 1-2 times with a mixed solution of anhydrous ethanol and n-hexane at 20-30℃ to obtain the fumaric acid tiamulin product.

[0027] As a further technical solution, the volume ratio of anhydrous ethanol to n-hexane in the anhydrous ethanol and n-hexane mixed solution is 2:1;

[0028] As a further technical solution, the temperature of the anhydrous ethanol and n-hexane mixed solution used for washing is 20-30℃.

[0029] The synthetic route of this invention is as follows:

[0030]

[0031] Compared with the prior art, the beneficial effects achieved by the present invention are as follows:

[0032] This invention employs a continuous flow reactor to react p-toluenesulfonic acid truncated pleurotin ester with cyclothioethane and diethylamine. During the reaction, by controlling the timing of the addition of p-toluenesulfonic acid truncated pleurotin ester, the cyclothioethane and diethylamine are first allowed to react to generate a portion of 2-diethylaminoethanethiol before the addition of p-toluenesulfonic acid truncated pleurotin ester. In the presence of 2-diethylaminoethanethiol, the probability of side reactions between cyclothioethane and p-toluenesulfonic acid truncated pleurotin ester is reduced, thus improving the yield and purity of tiamulin base. Furthermore, this invention utilizes blue light catalysis, reduces the sodium hydroxide content in the system during the p-toluenesulfonic acid truncated pleurotin ester reaction, and increases the diethylamine content to adjust the reaction rates of the addition and alkylation reactions, thereby further promoting the synthesis of tiamulin base, reducing side reactions, and improving the yield and purity of tiamulin base.

[0033] This invention adjusts the reaction solvent of the salt formation reaction of tiamulin fumarate to allow it to crystallize in a mixed solution of anhydrous ethanol and n-hexane. The crystals are then washed with the mixed solution of anhydrous ethanol and n-hexane, which effectively removes impurities from tiamulin fumarate, enabling it to meet the relevant requirements of the Chinese Veterinary Pharmacopoeia and the US Pharmacopoeia. Compared with traditional technologies, this invention eliminates the recrystallization process, avoiding product loss caused by recrystallization. Detailed Implementation

[0034] The present invention will be further described in detail below with reference to the embodiments.

[0035] Example 1

[0036] The preparation method of p-toluenesulfonic acid truncated pleurotin ester includes the following steps:

[0037] 1440 kg of methyl isobutyl ketone was added to 126 kg of truncated pleurotin, the mixture was heated to 60 °C, stirred and dissolved, and then 100 kg of 30% (w / w) alkaline solution (sodium hydroxide solution) was added dropwise, followed by 63.75 kg of 4-toluenesulfonyl chloride. A sulfonation reaction was carried out at 45-55 °C to generate truncated pleurotin ester of p-toluenesulfonic acid. The reaction was stopped after 10-20 min, yielding a reaction solution containing truncated pleurotin ester of p-toluenesulfonic acid. A sample was taken and tested, revealing 176 g of truncated pleurotin ester of p-toluenesulfonic acid, with a yield of 99.27%. The theoretical residual amount of sodium hydroxide in the reaction solution containing truncated pleurotin ester of p-toluenesulfonic acid obtained in this example is 16.7 kg.

[0038] Example 2

[0039] A method for preparing tiamulin alkaloid involves reacting p-toluenesulfonic acid truncated pleurotin ester with cyclothioethane and diethylamine in a continuous flow microchannel reactor to generate tiamulin alkaloid. The continuous flow microchannel reactor includes a mixing module A, a reaction module B, a mixing module C, and reaction modules D, E, and F connected in series. Each reaction module has a diameter of 200 micrometers and a liquid holding capacity of 4 mL.

[0040] The preparation method specifically includes:

[0041] First, the pressure of the continuous flow microchannel reactor is controlled at 2.2-2.6 MPa. The molar ratio of p-toluenesulfonic acid truncated pleurotin ester, cyclothioethane, and diethylamine is 1:1.06:2.3. Cyclothioethane and diethylamine are first pumped into mixing module A. After being mixed thoroughly in mixing module A for 1 minute, the mixture enters reaction module B. In reaction module B, an addition reaction is carried out at 62°C under 370 nm blue light for 10 seconds, generating a portion of 2-diethylaminoethanethiol, which then flows back into mixing module B. Simultaneously, based on p-toluenesulfonic acid truncated pleurotin ester, the reaction liquid containing p-toluenesulfonic acid truncated pleurotin ester is pumped... The mixture is introduced into mixing module B, where it is kept at 58°C for 20 seconds to mix thoroughly. Then, it flows sequentially through reaction modules D, E, and F, with the temperatures of modules D, E, and F controlled at 52°C, 47°C, and 42°C, respectively. The mixture is then kept under 370nm blue light for 30 seconds in modules D, E, and F. The remaining cyclothioethane and diethylamine continue to react to generate 2-diethylaminoethanethiol. Simultaneously, 2-diethylaminoethanethiol undergoes a alkylation reaction with p-toluenesulfonic acid truncated pleurotin ester to generate tiamulin base. Finally, the reaction solution is discharged, separated under vacuum, the aqueous layer is removed, and a methyl isobutyl ketone solution of tiamulin base is collected.

[0042] Example 3

[0043] A method for preparing tiamulin alkaloid involves reacting p-toluenesulfonic acid truncated pleurotin ester with cyclothioethane and diethylamine in a continuous flow microchannel reactor to generate tiamulin alkaloid. The continuous flow microchannel reactor includes a mixing module A, a reaction module B, a mixing module C, and reaction modules D, E, and F connected in series. Each reaction module has a diameter of 150 micrometers and a liquid holding capacity of 3 mL.

[0044] The preparation method specifically includes:

[0045] First, the pressure of the continuous flow microchannel reactor is controlled at 2.2-2.6 MPa. The molar ratio of p-toluenesulfonic acid truncated pleurotin ester, cyclothioethane, and diethylamine is 1:1.06:2.2. First, cyclothioethane and diethylamine are pumped into mixing module A. After being mixed thoroughly in mixing module A for 1 minute, the mixture is introduced into reaction module B. In reaction module B, an addition reaction is carried out under 65°C and 370nm blue light conditions for 8 seconds, generating a portion of 2-diethylaminoethanethiol. This then flows into mixing module B. Simultaneously, based on p-toluenesulfonic acid truncated pleurotin ester, the reaction solution containing p-toluenesulfonic acid truncated pleurotin ester is pumped into… After being thoroughly mixed at 60°C for 25 seconds in mixing module B, the mixture flows sequentially through reaction modules D, E, and F. The temperatures of reaction modules D, E, and F are controlled at 54°C, 48°C, and 42°C, respectively. The mixture is then subjected to 370nm blue light for 24 seconds in reaction modules D, E, and F. The remaining cyclothioethane and diethylamine continue to react to generate 2-diethylaminoethanethiol. Simultaneously, 2-diethylaminoethanethiol undergoes a alkylation reaction with p-toluenesulfonic acid truncated pleurotin ester to generate tiamulin base. Finally, the reaction solution is discharged, vacuum-separated, the aqueous layer is discharged, and the methyl isobutyl ketone solution of tiamulin base is collected.

[0046] Example 4

[0047] A method for preparing tiamulin alkaloid involves reacting p-toluenesulfonic acid truncated pleurotin ester with cyclothioethane and diethylamine in a continuous flow microchannel reactor to generate tiamulin alkaloid. The continuous flow microchannel reactor includes a mixing module A, a reaction module B, a mixing module C, and reaction modules D, E, and F connected in series. Each reaction module has a diameter of 250 micrometers and a liquid holding capacity of 5 mL.

[0048] The preparation method specifically includes:

[0049] First, the pressure of the continuous flow microchannel reactor is controlled at 2.2-2.6 MPa. The molar ratio of p-toluenesulfonic acid truncated pleurotin ester, cyclothioethane, and diethylamine is 1:1.06:2.4. Cyclothioethane and diethylamine are first pumped into mixing module A. After being mixed thoroughly in mixing module A for 1 minute, the mixture is introduced into reaction module B. In reaction module B, an addition reaction is carried out at 60°C under 370 nm blue light for 12 seconds, generating a portion of 2-diethylaminoethanethiol, which then flows into mixing module B. Simultaneously, based on p-toluenesulfonic acid truncated pleurotin ester, the reaction solution containing p-toluenesulfonic acid truncated pleurotin ester is pumped into… Mixing module B, after being held at 55℃ for 20 seconds to mix evenly, flows sequentially through reaction modules D, E, and F. The temperatures of reaction modules D, E, and F are controlled at 50℃, 45℃, and 40℃, respectively. The reaction is carried out under 370nm blue light for 36 seconds in reaction modules D, E, and F. The remaining cyclothioethane and diethylamine continue to react to generate 2-diethylaminoethanethiol. At the same time, 2-diethylaminoethanethiol undergoes a alkylation reaction with p-toluenesulfonic acid truncated pleurotin ester to generate tiamulin base. Finally, the reaction solution is discharged, vacuum separated, the aqueous layer is discharged, and the methyl isobutyl ketone solution containing tiamulin base is collected.

[0050] Evaluation of the reaction effects of Examples 2-4:

[0051] The methyl isobutyl ketone solutions containing tiamulin collected in Examples 2-4 were sampled and tested. The residual amount of p-toluenesulfonic acid truncated pleurotin ester and the conversion amount of the target product tiamulin ketone in the methyl isobutyl ketone solutions of tiamulin ketone were obtained by area normalization method. The content of tiamulin ketone in the methyl isobutyl ketone solutions of tiamulin ketone were determined by external standard method, and the yield of tiamulin ketone in Examples 2-4 was calculated. The results are shown in Table 1.

[0052] Table 1:

[0053]

[0054] In Examples 2-4, the average yield of tylosin alkaloid was 98.1%.

[0055] Example 5

[0056] The preparation method of tiamulin fumarate (salt formation reaction) includes the following steps:

[0057] The methyl isobutyl ketone solution containing tiamulin alkaloid (containing 4.8 kg of tiamulin alkaloid) collected in Examples 2-4 was combined and washed with water. Then, it was vacuum distilled at 70-80°C until no bubbles were generated. After cooling to room temperature, 2.25 kg of a mixed solution of anhydrous ethanol and n-hexane (volume ratio of anhydrous ethanol to n-hexane was 2:1) was added. The temperature was raised to 50-60°C and stirred to dissolve. Then, 1.15 kg of fumaric acid was added. The temperature was maintained at 52-58°C for 1.5 h. After cooling to 10°C, the crystals were cooled and filtered. The crystals were washed twice with a mixed solution of anhydrous ethanol and n-hexane at 20-30°C to obtain 5.91 kg of tiamulin fumarate product. The purity of the tiamulin fumarate product was 98.4%, and the reaction yield of the salt formation step was 96.6%.

[0058] In Examples 1-5 of this invention, truncated pleurotin is used as a raw material. It undergoes a sulfonation reaction with 4-toluenesulfonyl chloride to generate truncated pleurotin p-toluenesulfonic acid ester. Then, truncated pleurotin p-toluenesulfonic acid ester reacts with cyclothioethane and diethylamine in a continuous flow microchannel reactor to generate tiamulin base. It then reacts with fumaric acid to form a salt, generating tiamulin fumarate. After crystallization, washing, and drying, the tiamulin fumarate product is obtained. The overall yield of the entire synthetic route is 94.1%.

[0059] The fumarate tiamulin product prepared in Example 5 of this invention was tested according to the methods described in the 2020 edition of the Chinese Veterinary Pharmacopoeia and the United States Pharmacopoeia, and it complies with the relevant provisions of the 2020 edition of the Chinese Veterinary Pharmacopoeia and the United States Pharmacopoeia.

[0060] Comparative Example 1:

[0061] A method for preparing tiamulin base involves reacting p-toluenesulfonic acid truncated pleurotin ester with cyclothioethane and diethylamine in a continuous flow microchannel reactor. The continuous flow microchannel reactor includes a mixing module A, a reaction module B, C, D, and E connected in series. Each reaction module has a diameter of 200 micrometers and a liquid holding capacity of 4 mL.

[0062] The preparation method specifically includes:

[0063] First, the pressure of the continuous flow microchannel reactor is controlled at 2.2-2.6 MPa. The molar ratio of p-toluenesulfonic acid truncated pleurotin ester, cyclothioethane, and diethylamine is 1:1.06:2.2. Cyclothioethane and diethylamine are first mixed and stirred until homogeneous to obtain a mixed solution of cyclothioethane and diethylamine. Then, the mixed solution of cyclothioethane and diethylamine and the reaction solution containing p-toluenesulfonic acid truncated pleurotin ester are pumped separately into mixing module A. After being mixed evenly in mixing module A for 1 minute, the solution enters reaction module B, and flows sequentially through reaction modules B, C, D, and E. The temperatures of reaction modules B, C, D, and E are controlled at 58℃, 52℃, 47℃, and 42℃, respectively. The reaction is carried out under 370nm blue light for 40 seconds in reaction modules B, C, D, and E to generate tiamulin alkaloid. Finally, the reaction solution is discharged, vacuum separation is performed, the aqueous layer is discharged, and a methyl isobutyl ketone solution of tiamulin alkaloid is collected.

[0064] Comparative Example 2

[0065] A method for preparing tiamulin alkaloid involves reacting p-toluenesulfonic acid truncated pleurotin ester with cyclothioethane and diethylamine in a continuous flow microchannel reactor to generate tiamulin alkaloid. The continuous flow microchannel reactor comprises a mixing module A, a reaction module B, a reaction module C, a reaction module D, a mixing module E, and reaction modules F, G, and H connected in series. Each reaction module has a diameter of 200 micrometers and a liquid holding capacity of 4 mL.

[0066] The preparation method specifically includes:

[0067] First, the pressure of the continuous flow microchannel reactor was controlled at 2.2-2.6 MPa. The molar ratio of truncated pleurotin ester of p-toluenesulfonic acid, cyclothioethane, and diethylamine was 1:1.06:2.2. Cyclothioethane and diethylamine were first pumped separately into reaction module A. After mixing thoroughly in reaction module A for 1 minute, the mixture flowed through reaction modules B, C, and D. Reaction modules B, C, and D were maintained at 65°C, and the blue light was set to 370 nm. The mixture remained in reaction modules B, C, and D for 30 seconds to undergo an addition reaction to generate 2-diethylamine. Ethyl mercaptan is then introduced into mixing module E, while a reaction solution containing truncated pleurotin ester of p-toluenesulfonic acid is pumped into mixing module E. After being mixed evenly in mixing module E for 20 seconds, the solution flows sequentially through reaction modules F, G, and H. The temperatures of reaction modules F, G, and H are controlled at 52°C, 47°C, and 42°C, respectively. The reaction is carried out under 370nm blue light for 40 seconds in reaction modules F, G, and H to generate tiamulin base. Finally, the reaction solution is discharged, vacuum separation is performed, the aqueous layer is discharged, and the methyl isobutyl ketone solution of tiamulin base is collected.

[0068] Comparative Example 3

[0069] A method for preparing tiamulin alkaloid is the same as in Example 2, except that blue light is not turned on in any of the reaction modules;

[0070] This comparative example ultimately yielded a collected solution of tiamulin alkaloid in methyl isobutyl ketone.

[0071] Comparative Example 4

[0072] A method for preparing tiamulin alkaloid is the same as in Example 2, except that the molar ratio of p-toluenesulfonic acid truncated pleurotin ester, cyclothioethane, and diethylamine is 1:1.06:1.1.

[0073] This comparative example ultimately yielded a collected solution of tiamulin alkaloid in methyl isobutyl ketone.

[0074] Comparative Example 5

[0075] A method for preparing tiamulin alkaloid is the same as in Example 2, except that the reaction solution containing 1.76 kg of truncated pleurotin ester from Example 1 is taken, and sodium hydroxide is added to it until the reaction solution containing truncated pleurotin ester contains 0.39 kg of sodium hydroxide. This solution is then pumped into mixing module C (i.e., this comparative example increases the concentration of sodium hydroxide in the reaction system).

[0076] This comparative example ultimately yielded a collected solution of tiamulin alkaloid in methyl isobutyl ketone.

[0077] Comparative Example 6

[0078] A method for preparing tiamulin alkaloids includes the following steps:

[0079] A certain amount of the reaction solution containing p-toluenesulfonic acid truncated pleurotin ester prepared in Example 1 was taken, and after vacuum separation and washing with pure water to remove the alkali, it was evaporated and desoluble to obtain p-toluenesulfonic acid truncated pleurotin ester (1.87 kg based on pure product).

[0080] According to the molar ratio of p-toluenesulfonic acid truncated pleurotin ester, cyclothioethane, and diethylamine 1:1.06:2.2, 1.76 kg of p-toluenesulfonic acid truncated pleurotin ester was dissolved in ethyl acetate and then added to a reaction vessel together with cyclothioethane and diethylamine. The reaction was refluxed at 50°C for 4 hours. The reaction solution was controlled at mid-state. At this time, the starting material p-toluenesulfonic acid truncated pleurotin ester no longer decreased. Vacuum separation was performed, the aqueous layer was discharged, and the methyl isobutyl ketone solution of tiamulin base was collected.

[0081] Comparative Example 7

[0082] A method for preparing tiamulin alkaloid is the same as that for Comparative Example 6, except that the reaction temperature is 60°C.

[0083] This comparative example ultimately yielded a collected solution of tiamulin alkaloid in methyl isobutyl ketone.

[0084] Comparative Example 8

[0085] A method for preparing tiamulin alkaloid, comprising the following steps

[0086] Take the reaction solution containing p-toluenesulfonic acid truncated pleurotin ester prepared in Example 1 (containing 1.76 kg of p-toluenesulfonic acid truncated pleurotin ester), add 0.575 kg of sodium hydroxide solution with a mass concentration of 40% dropwise, then add 0.42 kg of 2-diethylaminoethyl mercaptan, and then react at 45°C for 25 min until the residual p-toluenesulfonic acid truncated pleurotin ester is less than 0.05%, separate the layers under vacuum, remove the aqueous layer, and collect the methyl isobutyl ketone solution of tiamulin base.

[0087] Comparative Example 9

[0088] A method for preparing tiamulin alkaloid, comprising the following steps

[0089] Take the reaction solution containing p-toluenesulfonic acid truncated pleurotin ester prepared in Example 1 (containing 1.76 kg of p-toluenesulfonic acid truncated pleurotin ester), add 0.42 kg of 2-diethylaminoethyl mercaptan dropwise, and then react at 45°C for 85 min until the residual p-toluenesulfonic acid truncated pleurotin ester is less than 0.05%. Vacuum separation is performed, the aqueous layer is removed, and the methyl isobutyl ketone solution of tiamulin base is collected.

[0090] Evaluation of the response effects of comparison examples 1-9

[0091] Samples of tiamulin alkaloid solutions collected in Comparative Examples 1-9 were taken and analyzed. The residual amount of p-toluenesulfonic acid truncated pleurotin ester and the conversion amount of the target product tiamulin alkaloid in the tiamulin alkaloid solutions were obtained by area normalization method. The content of tiamulin alkaloid in the tiamulin alkaloid solutions was determined by external standard method, and the yield of tiamulin alkaloid was calculated. The results are shown in Table 2.

[0092] Table 2:

[0093]

[0094]

[0095] The embodiments described above are merely preferred embodiments of the present invention, and not an exhaustive list of all possible implementations of the present invention. Any obvious modifications made by those skilled in the art without departing from the principles and spirit of the present invention should be considered to be included within the scope of protection of the claims of the present invention.

Claims

1. A method for preparing tiamulin fumarate, characterized in that, Includes the following steps: First, pylori is used as a raw material and reacted with 4-toluenesulfonyl chloride to generate pylori ester of p-toluenesulfonic acid. Then, pylori ester of p-toluenesulfonic acid reacts with cyclothioethane and diethylamine in a continuous flow microchannel reactor to generate tiamulin base. Then, it reacts with fumaric acid to form a salt to generate tiamulin fumarate. The continuous flow microchannel reactor comprises a mixing module A, a reaction module B, a mixing module C, a reaction module D, a reaction module E, and a reaction module F connected in series. The specific steps for the reaction of truncated pleurotin methylbenzenesulfonate with cyclothioethane and diethylamine in the continuous flow microchannel reactor to generate tiamulin alkaloid include: First, cyclothioethane and diethylamine are pumped into mixing module A. After being mixed evenly in mixing module A, they enter reaction module B, where an addition reaction occurs to generate part of 2-diethylaminoethanethiol. Then, the mixture flows into mixing module C, where it is mixed with a solution of p-toluenesulfonic acid truncated pleurotin ester. After mixing in mixing module C, the mixture flows sequentially through reaction modules D, E, and F. In reaction modules D, E, and F, the remaining cyclothioethane and diethylamine react to generate 2-diethylaminoethanethiol. Simultaneously, 2-diethylaminoethanethiol undergoes a alkylation reaction with p-toluenesulfonic acid truncated pleurotin ester to generate tiamulin base. The reaction solution containing tiamulin base is then discharged. Blue light is activated in reaction modules B, D, E, and F. The wavelength of the blue light is 460-480nm.

2. The method for preparing tiamulin fumarate according to claim 1, characterized in that, The molar ratio of truncated pleurotin methylbenzenesulfonic acid ester, cyclothioethane and diethylamine pumped in per unit time is 1:1.01-1.10:2.0-2.

5.

3. The method for preparing tiamulin fumarate according to claim 1, characterized in that, The temperature of reaction module B is 60-65℃, the reaction temperature of reaction module D is 40-55℃, and the temperature decreases by 4-6℃ from reaction module D to reaction module F.

4. The method for preparing tiamulin fumarate according to claim 1, characterized in that, The pressure of the microchannel reactor is controlled at 2-3 MPa.

5. The method for preparing tiamulin fumarate according to claim 1, characterized in that, The residence time of the material in mixing module A is 45-75 seconds. The residence time of the material in mixing module C is 15-25 seconds.

6. The method for preparing tiamulin fumarate according to claim 1, characterized in that, The reaction residence time of the material in reaction module B is 8-12 seconds; The total reaction residence time in reaction modules D to F is 24-36 s.

7. The method for preparing tiamulin fumarate according to claim 1, characterized in that, The truncated pleurotin ester solution is a reaction solution containing truncated pleurotin ester obtained by sulfonation reaction. Using truncated pleurotin as a raw material, a sulfonation reaction is carried out with 4-toluenesulfonyl chloride to produce truncated pleurotin p-toluenesulfonic acid ester, specifically including the following steps: Add methyl isobutyl ketone solvent to truncated pleurotin, heat to 60°C, stir to dissolve, add alkaline water dropwise, add 4-toluenesulfonyl chloride, and carry out sulfonation reaction at 45-55°C to generate truncated pleurotin ester of methylbenzenesulfonate. After reacting for 10-20 minutes, stop the reaction to obtain a reaction solution containing truncated pleurotin ester of p-methylbenzenesulfonate.

8. The method for preparing tiamulin fumarate according to claim 1, characterized in that, The discharged reaction solution containing tiamulin alkaloids was separated into layers under vacuum conditions. The aqueous layer was removed, and the organic layer of tiamulin alkaloids was collected and reacted with fumaric acid to form a salt. The reaction with fumaric acid to form a salt specifically includes: washing the organic layer of tiamulin base with water, then vacuum distilling it at 70-80℃ until no bubbles are generated, cooling it to room temperature, adding a mixed solution of anhydrous ethanol and n-hexane, heating it to 50-60℃, stirring to dissolve it, adding fumaric acid, keeping it at 52-58℃ for 1.5 hours, cooling it to 10℃, cooling to crystallize, filtering it, and washing the crystals 1-2 times with a mixed solution of anhydrous ethanol and n-hexane to obtain the fumaric acid tiamulin product.

9. The method for preparing tiamulin fumarate according to claim 8, characterized in that, The volume ratio of anhydrous ethanol to n-hexane in the mixed solution of anhydrous ethanol and n-hexane is 2:1; The temperature of the anhydrous ethanol and n-hexane mixed solution used for washing is 20-30℃.

Citation Information

Patent Citations

  • Preparation method of high-yield tiamulinfumarate

    CN102875432A

  • One-pot method for synthesizing tiamulin

    CN104447449A